Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | CHRM2 | P08172 | 4/20 | 0.38 |
| ▸ | CHRM5 | P08912 | 4/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 4/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.31 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18802700 | 1.00 | THRB (0.42) | THRBLMNACHRM2CHRM5CHRM1 | |
| SCHEMBL18596480 | 0.86 | THRB (0.36) | THRBLMNACHRM2CHRM5CHRM1 | |
| SCHEMBL14532196 | 0.80 | THRB (0.52) | THRBLMNA | |
| SCHEMBL3469193 | 0.77 | THRB (0.55) | THRBLMNA | |
| SCHEMBL15496477 | 0.77 | THRB (0.55) | THRBLMNA | |
| SCHEMBL9604672 | 0.77 | THRB (0.44) | THRBLMNACHRM2CHRM5CHRM1 | |
| SCHEMBL22837190 | 0.75 | THRB (0.38) | THRBLMNA | |
| SCHEMBL29306262 | 0.75 | CHRM2 (0.35) | CHRM2CHRM5CHRM1 | |
| SCHEMBL19760529 | 0.75 | THRB (0.38) | THRBLMNA | |
| SCHEMBL15703229 | 0.75 | CHRM2 (0.35) | CHRM2CHRM5CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10874103-B2 | Antibacterial composition comprising an acetal or a long-chain alkyl hexitane ether | TEREOS STARCH & SWEETENERS BELGIUM (BE) | 2020-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10874103-B2 | Antibacterial composition comprising an acetal or a long-chain alkyl hexitane ether | AAAS, AADAC, DPM1 | THRB 3491/4885LMNA 2772/4885CHRM2 4800/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.